Frank X. Leonard, President, CNS Cancers US at NovoCure Ltd (NVCR), sold 42,378 shares at $117.00 ($4.8M) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $4.8M NVCR by President, CNS Cancers US. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.00 | 417 | $45K | 0.9% |
| 2 | $108.00 | 7,826 | $845K | 17.7% |
| 3 | $108.00 | 7,500 | $810K | 17.0% |
| 4 | $108.00 | 5,517 | $596K | 12.5% |
| 5 | $114.00 | 7,183 | $819K | 17.2% |
| 6 | $115.03 | 526 |
| $61K |
| 1.3% |
| 7 | $115.03 | 526 | $61K | 1.3% |
| 8 | $117.00 | 1,010 | $118K | 2.5% |
| 9 | $119.01 | 2,345 | $279K | 5.8% |
| 10 | $119.01 | 2,345 | $279K | 5.8% |
| 11 | $120.00 | 7,183 | $862K | 18.1% |
| Total | $112.66 avg | 42,378 | $4.8M | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |